The aim of modern RDS management is to maximise survival while minimising complications such as air leaks and BPD. Many strategies for prevention and treatment of RDS and providing early respiratory support have been tested in clinical trials and are summarised in updated systematic reviews, all of which inform these guidelines.
The overall aim is to avoid MV if possible while endeavouring to give surfactant as early as possible in the course of RDS, preferably using LISA methods.
EUROPEAN CONSENSUS GUIDELINES UPDATE 2022
115-2023-MARK